Cargando…

Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19

Detalles Bibliográficos
Autores principales:	Asnani, Mukta, Hayer, Katharina E., Naqvi, Ammar S., Zheng, Sisi, Yang, Scarlett Y., Oldridge, Derek, Ibrahim, Fadia, Maragkakis, Manolis, Gazzara, Matthew R., Black, Kathryn L., Bagashev, Asen, Taylor, Deanne, Mourelatos, Zissimos, Grupp, Stephan A., Barrett, David, Maris, John M., Sotillo, Elena, Barash, Yoseph, Thomas-Tikhonenko, Andrei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214268/ https://www.ncbi.nlm.nih.gov/pubmed/31591467 http://dx.doi.org/10.1038/s41375-019-0580-z

Ejemplares similares

Aberrant splicing in B-cell acute lymphoblastic leukemia
por: Black, Kathryn L, et al.
Publicado: (2018)

Aberrant splicing in B-cell acute lymphoblastic leukemia
por: Black, Kathryn L, et al.
Publicado: (2019)

CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum
por: Bagashev, Asen, et al.
Publicado: (2018)

Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies
por: Zheng, Sisi, et al.
Publicado: (2022)

Ribothrypsis, a novel process of canonical mRNA decay, mediates ribosome-phased mRNA endonucleolysis
por: Ibrahim, Fadia, et al.
Publicado: (2018)

TERA-Seq: true end-to-end sequencing of native RNA molecules for transcriptome characterization
por: Ibrahim, Fadia, et al.
Publicado: (2021)

Direct long-read RNA sequencing identifies a subset of questionable exitrons likely arising from reverse transcription artifacts
por: Schulz, Laura, et al.
Publicado: (2021)

CLIPSeqTools—a novel bioinformatics CLIP-seq analysis suite
por: Maragkakis, Manolis, et al.
Publicado: (2016)

Kc167, a widely used Drosophila cell line, contains an active primary piRNA pathway
por: Vrettos, Nicholas, et al.
Publicado: (2017)

FBXW7β isoform drives transcriptional activation of the proinflammatory TNF cluster in human pro-B cells
por: Yang, Scarlett Y., et al.
Publicado: (2022)

Modulation of Aub–TDRD interactions elucidates piRNA amplification and germplasm formation
por: Vrettos, Nicholas, et al.
Publicado: (2020)

Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies
por: Ang, Zhiwei, et al.
Publicado: (2023)

Sequence-dependent but not sequence-specific piRNA adhesion traps mRNAs to the germ plasm
por: Vourekas, Anastassios, et al.
Publicado: (2016)

High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance
por: Cortés-López, Mariela, et al.
Publicado: (2022)

Mili and Miwi target RNA repertoire reveals piRNA biogenesis and function of Miwi in spermiogenesis
por: Vourekas, Anastassios, et al.
Publicado: (2012)

Mitochondrial protein BmPAPI modulates the length of mature piRNAs
por: Honda, Shozo, et al.
Publicado: (2013)

Integrative deep models for alternative splicing
por: Jha, Anupama, et al.
Publicado: (2017)

Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy
por: Rabilloud, Tracy, et al.
Publicado: (2021)

MAJIQ-SPEL: web-tool to interrogate classical and complex splicing variations from RNA-Seq data
por: Green, Christopher J, et al.
Publicado: (2018)

The RNA helicase MOV10L1 binds piRNA precursors to initiate piRNA processing
por: Vourekas, Anastassios, et al.
Publicado: (2015)

The MOV10 RNA helicase is a dosage-dependent host restriction factor for LINE1 retrotransposition in mice
por: Guan, Yongjuan, et al.
Publicado: (2023)

Enhanced Integrated Gradients: improving interpretability of deep learning models using splicing codes as a case study
por: Jha, Anupama, et al.
Publicado: (2020)

Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro
por: Ledererova, Aneta, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Nasrallah, MacLean P, et al.
Publicado: (2021)

Roles and functions of HIV-1 Tat protein in the CNS: an overview
por: Bagashev, Asen, et al.
Publicado: (2013)

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells
por: Ruella, Marco, et al.
Publicado: (2015)

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis
por: Fischer, Jeannette, et al.
Publicado: (2017)

Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy
por: Nunez, Daniel, et al.
Publicado: (2023)

CD-19 CART therapy and orthostatic hypotension: a single center retrospective cohort study
por: Patel, Ashish, et al.
Publicado: (2022)

Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing
por: Chen, Gregory M., et al.
Publicado: (2023)

Subclones of bone marrow CD34(+) cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2022)

Ancient antagonism between CELF and RBFOX families tunes mRNA splicing outcomes
por: Gazzara, Matthew R., et al.
Publicado: (2017)

IL-10 is Predominantly Produced by CD19(low)CD5(+) Regulatory B Cell Subpopulation: Characterisation of CD19 (high) and CD19(low) Subpopulations of CD5(+) B cells
por: Lee, Jae Ho, et al.
Publicado: (2011)

CD34(+)CD19(−)CD22(+) B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies
por: Bueno, Clara, et al.
Publicado: (2022)

Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
por: Heard, Amanda, et al.
Publicado: (2022)

High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate
por: Ingle, Gladys S, et al.
Publicado: (2008)

T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies
por: Velasquez, Mireya Paulina, et al.
Publicado: (2016)

Anti-CD19 chimeric antigen receptor targeting of CD19 + acute myeloid leukemia
por: Ma, Gina, et al.
Publicado: (2018)

Identifying common transcriptome signatures of cancer by interpreting deep learning models
por: Jha, Anupama, et al.
Publicado: (2022)

Subclonal heterogeneity and evolution in breast cancer
por: Mavrommati, Ioanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hou41v7gvs6ddfurj0ju4ma8go